The North America Blood Lancets Market would witness market growth of 7.8% CAGR during the forecast period (2019-2025). North America represented a large market share in 2018, and this trend is expected to continue over the forecast period. The substantial growth rate can be associated with the robust use and availability of blood lancet availability in this region. Furthermore, diabetes incidence is rising at a significant pace in the U.S. For example, more than 100 million U.S. people currently live with diabetes or prediabetes according to the Center for Disease Control and Prevention. In 2015, diabetes was the seventh-largest cause of death in the U.S.
On the basis of extensive use of these in diabetes treatment, the disposal lancets have thrived as a pricking needle to draw blood from patients, especially in-home care settings. Significant over-the-counter (OTC) sales of disposable lancets have occurred over the last few years. Advances in capillary blood collection techniques used in lancets have greatly improved comfort and safety features for patients and health care professionals alike. Medical technologies aim to unveil disposable lancets that reduce patients' as well as the caregivers‘ risk of cross-contamination or injury. In addition, single-release functions have been continuously invented over the past few years, providing a substantial boost to competition in the market for disposable lancets.
Key indicators of medical devices on the disposable lancets market aim to unveil tools that render their use easy for patients and make the process of drawing blood almost painless. They equip the devices with cutting-edge capillary blood engineering. A few players on the market for disposable lancets aim to meet the needs of point-of-care patients, particularly those used for diabetes treatment. Some prominent ones aim to develop disposable lancets that can be used for multiple purposes. Additionally, lancets with precision cut tips are disposable.
Based on Type, the market is segmented into Vacuum Blood Lancets, Safety Blood Lancets and Standard Blood Lancets. Based on End Users, the market is segmented into Homecare, Hospitals and Clinics, Blood Banks and other End Users. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Blood Lancets Market in North America is expected to register a CAGR of 7.8% during the forecast period (2019-2025)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Haemonetics Corporation, Nipro Corporation, Sarstedt AG & Company, F.L. Medical S.r.l., Socorex Isba SA, and PL Medical Co., LLC
Market Segmentation:
By Type
By End Users
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
